Browsing by Author Fox, Stephen B.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 11 of 11
Issue DateTitleAuthor(s)Citation
2012BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study GroupdeFazio, Anna; Emmanuel, Catherine; Alsop, Kathryn; Birrer, Michael; Bowtell, David D L; Dobrovic, Alexander; Fereday, Sian; Fox, Stephen B.; Friedlander, Michael; George, Joshy; Meldrum, Cliff; Mitchell, Gillian; Stewart, Colin; Webb, Penelope M.; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium InstituteBRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group, Journal of Clinical Oncology, vol.30, 21, 2012,pp 2654-2663
2011Enhanced RAD21 cohesin expression confers poor prognosis and resistance to chemotherapy in high grade luminal, basal and HER2 breast cancersMcNeil, Catriona; O'Toole, Sandra; Fox, Stephen B.; McKay, Michael J.; Millar, Ewan; Natrajan, Rachael; Patra, Jennifer; Ramsay, Robert G.; Reis-Filho, Jorge; Sutherland, Robert L.; Swagemakers, Sigrid; Tomaszewski, Jonathan M.; van der Spek, Peter; Verschoor, Sandra; Xu, Huiling; Yan, Max; Yan, Yuqian; Western Clinical School: Medicine (Westmead); Central Clinical School: PathologyEnhanced RAD21 cohesin expression confers poor prognosis and resistance to chemotherapy in high grade luminal, basal and HER2 breast cancers, Breast Cancer Research, vol.13, 1, 2011,pp R9-1-R9-36
2012Enhanced RAD21 cohesin expression confers poor prognosis in BRCA2 and BRCAX, but not BRCA1 familial breast cancersMcKay, Michael; Fox, Stephen B.; Haviv, Izhak; Shield-Artin, Kristy; Waddell, Nic; Xu, Huiling; Yan, Max; MedicineEnhanced RAD21 cohesin expression confers poor prognosis in BRCA2 and BRCAX, but not BRCA1 familial breast cancers, Breast Cancer Research, vol.14, 2, 2012,pp 1-11
2010Establishment of the Australian In Situ Hybridization Program for the Assessment of HER2 Amplification in Breast Cancer: A Model for the Introduction of New Biomarkers Into Clinical PracticeBilous, Michael; Armes, Jane; Bell, Richard (Prof); Cummings, Margaret; Farshid, G; Fox, Stephen B.; Francis, Glenn; Haswell, Martin; McCue, Glenda; Morey, Adrienne; Raymond, W.; Robbins, Peter; Western Clinical School: Medicine (Westmead)Establishment of the Australian In Situ Hybridization Program for the Assessment of HER2 Amplification in Breast Cancer: A Model for the Introduction of New Biomarkers Into Clinical Practice, Diagnostic Molecular Pathology, vol.19, 4,pp 187-193
2014Expression of E6AP and PML predicts for prostate cancer progression and cancer-specific deathHorvath, Lisa; Kench, James; Veillard, Anne-Sophie; Birch, S E; Chan, A-L; Chan, Peter; Chiam, K; Fox, Stephen B.; Haupt, S; Haupt, Y; Stricker, Phillip; Takano, E; Central Clinical School: Medicine; School of Medical Sciences: Pathology; School of Public Health: NH&MRC Clinical Trials CentreExpression of E6AP and PML predicts for prostate cancer progression and cancer-specific death, Annals of Oncology, vol.25, 12, 2014,pp 2392-2397
2015The genomic landscape of phaeochromocytomaBenn, Diana; Clifton-Bligh, Roderick; Gill, Anthony; Robinson, Bruce; Flynn, Aidan; Fox, Stephen B.; George, Joshy; Hicks, Rodney J.; Hogg, Annette; James, Paul; Li, Jason; McArthur, Grant A.; Tothill, Richard W.; Trainer, Alison; Waldeck, Kelly; Northern Clinical School: Kolling Institute; Northern Clinical School: Medicine; Northern Clinical School: Pathology; Northern Clinical School: MedicineThe genomic landscape of phaeochromocytoma, Journal of Pathology, vol.236, 1, 2015,pp 78-89
2017Lessons learnt from implementation of a Lynch syndrome screening program for patients with gynaecological malignancyGard, Greg; Gill, Anthony; Hogg, Russell; Turchini, John; Ahadi, Mahsa S; Clarkson, Adele; Crook, Ashley; Dooley, Susan J.; Fellowes, Andrew; Field, M; Fox, Stephen B.; Ho, Musei; Maidens, Jayne; McEvoy, Christopher; Mcilroy, K; Najdawi, Fedaa; Nevell, D; Pickett, Justine; Scott, Rodney J; Sheen, Amy; Sioson, Loretta; Valmadre, Susan; Nepean Clinical School: Obstetrics & Gynaecology; Northern Clinical School: Pathology; Western Clinical School: Medicine (Westmead); Northern Clinical School: PathologyLessons learnt from implementation of a Lynch syndrome screening program for patients with gynaecological malignancy, Pathology, vol.49, 5, 2017,pp 457-464
2010Loss of STARD10 expression identifies a group of poor prognosis breast cancers independent of HER2/Neu and triple negative statusMcNeil, Catriona; O'Toole, Sandra; Biankin, Andrew V.; Crea, Paul; et al, various; Fox, Stephen B.; Lee, Cheok; Millar, E.; Murphy, Niamh; Olayioye, Monilola; Segara, Davendra; Western Clinical School: Medicine (Westmead); Central Clinical School: PathologyLoss of STARD10 expression identifies a group of poor prognosis breast cancers independent of HER2/Neu and triple negative status, International Journal of Cancer, vol.126, 6,pp 1445-1453
2008Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome.deFazio, Anna; Australian Ovarian Cancer Study Group, (AOCSG); Bowtell, David D L; Brown, Robert; Chiew, Yoke-Eng; Etemadmoghadam, Dariush; Fereday, Sian; Fox, Stephen B.; George, Joshy; Gertig, Dorota; Haviv, Izhak; Hung, Jillian A.; Johnson,, Daryl S.; Lade, Stephen; Locandro, Bianca; Tinker, Anna V.; Tothill, Richard W.; Traficante, Nadia; Trivett, Melanie K.; Western Clinical School: Westmead Millennium InstituteNovel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome., Clinical Cancer Research, vol.14, 16, 2008,pp 5198-5208
2014RAD21 cohesin overexpression is a prognostic and predictive marker exacerbating poor prognosis in KRAS mutant colorectal carcinomasMcKay, Michael; Deb, Siddhartha; Fox, Stephen B.; George, Joshy; Hawkins, Nicholas; Li, J; Mortensen, Neil James; Ramsay, Robert G.; Tuynman, Jurriaan; Ward, Robyn; Xu, Huiling; Yan, Yuqian; MedicineRAD21 cohesin overexpression is a prognostic and predictive marker exacerbating poor prognosis in KRAS mutant colorectal carcinomas, British Journal of Cancer, vol.110, 6, 2014,pp 1606-1613
2013Testing for ALK rearrangement in lung adenocarcinoma: A multicenter comparison of immunohistochemistry and fluorescent in situ hybridizationBoyer, Michael; Horvath, Lisa; O'Toole, Sandra; Yip, Po Yee; Cooper, Wendy; Fox, Stephen B.; Kohonen-Corish, Maija R.J.; McCaughan, Brian; Rogers, Toni-Maree; Russell, Prudence; Selinger, Christina; Solomon, Benjamin; Wainer, Zoe; Wright, Gavin; Central Clinical School: Medicine; Central Clinical School: Medicine; Central Clinical School: Pathology; MedicineTesting for ALK rearrangement in lung adenocarcinoma: A multicenter comparison of immunohistochemistry and fluorescent in situ hybridization, Modern Pathology, vol.26, 12, 2013,pp 1545-1553